QIPT · As filed with the SEC
Quipt Home Medical cash flow statement, by fiscal year
The statement as Quipt Home Medical presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD
| USD | FY2025 Year ended Sep 30, 2025 | FY2024 Year ended Sep 30, 2024 | FY2023 Year ended Sep 30, 2023 | FY2022 Year ended Sep 30, 2022 | FY2021 Year ended Sep 30, 2021 | FY2020 Year ended Sep 30, 2020 |
|---|---|---|---|---|---|---|
| Operating activities | ||||||
| Net loss | — | (6,763,000) | — | — | — | — |
| Net loss | (10,701,000) | — | — | — | — | — |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||
| Depreciation and amortization | 45,482,000 | 44,581,000 | — | — | — | — |
| Stock-based compensation | 4,035,000 | 2,484,000 | — | — | — | — |
| Gain on disposals of property and equipment | (1,225,000) | (107,000) | — | — | — | — |
| Amortization of financing costs and accretion of purchase price payable | 563,000 | 551,000 | — | — | — | — |
| Gain on foreign currency transactions | — | (43,000) | — | — | — | — |
| Loss (gain) on foreign currency transactions | 367,000 | — | — | — | — | — |
| Share of loss in equity method investment | 324,000 | 309,000 | — | — | — | — |
| Change in fair value of derivative liability - interest rate swap | (452,000) | 1,122,000 | — | — | — | — |
| Deferred income taxes | 85,000 | 342,000 | — | — | — | — |
| Right-of-use operating lease amortization and interest | 6,434,000 | 5,974,000 | — | — | — | — |
| Payments of operating leases, including interest | (6,138,000) | (5,386,000) | — | — | — | — |
| Adjustments to purchase price payable | — | (29,000) | — | — | — | — |
| Change in working capital, net of acquisitions: | ||||||
| Net decrease (increase) in accounts receivable | 2,575,000 | (3,294,000) | — | — | — | — |
| Net increase in inventory | (2,417,000) | (3,420,000) | — | — | — | — |
| Net decrease (increase) in prepaid and other current assets | 2,193,000 | (3,124,000) | — | — | — | — |
| Net decrease in deferred revenue | (21,000) | (943,000) | — | — | — | — |
| Net increase (decrease) in accounts payables and accrued liabilities | (3,412,000) | 3,127,000 | — | — | — | — |
| Net cash flow provided by operating activities | 37,692,000 | 35,381,000 | — | — | — | — |
| Investing activities | ||||||
| Purchase of property and equipment | (12,354,000) | (10,313,000) | — | — | — | — |
| Cash proceeds from sale of property and equipment | 1,233,000 | 210,000 | — | — | — | — |
| Cash paid for acquisitions, net of cash acquired | (21,824,000) | (210,000) | — | — | — | — |
| Net cash flow used in investing activities | (32,945,000) | (10,313,000) | — | — | — | — |
| Financing activities | ||||||
| Repayments of equipment loans and SBA loan | — | (26,792,000) | — | — | — | — |
| Repayments of equipment loans | (24,472,000) | — | — | — | — | — |
| Repayments of finance leases | (1,436,000) | (1,579,000) | — | — | — | — |
| Borrowings on delayed-draw term loan | 17,400,000 | — | — | — | — | — |
| Repayments of delayed-draw term loan and term loan | (3,668,000) | (3,450,000) | — | — | — | — |
| Gross borrowings on the revolving credit facility | 18,250,000 | 17,100,000 | — | — | — | — |
| Gross repayments on the revolving credit facility | (13,623,000) | (10,777,000) | — | — | — | — |
| Issuance costs relating to credit facility | — | (60,000) | — | — | — | — |
| Other, net | (79,000) | — | — | — | — | — |
| Repurchase of shares, net of issuance costs | (130,000) | — | — | — | — | — |
| Settlement of restricted stock units | — | (213,000) | — | — | — | — |
| Proceeds from exercise of stock options | — | 568,000 | — | — | — | — |
| Payments of purchase price payable | — | (944,000) | — | — | — | — |
| Net cash flow (used in) provided by financing activities | (7,758,000) | (26,147,000) | — | — | — | — |
| Net increase (decrease) in cash | (3,011,000) | (1,079,000) | — | — | — | — |
| Effect of exchange rate changes on cash held in foreign currencies | (247,000) | 44,000 | — | — | — | — |
| Cash, beginning of year | 16,174,000 | 17,209,000 | — | — | — | — |
| Cash, end of year | 12,916,000 | 16,174,000 | — | — | — | — |
| Supplemental cash flow information | ||||||
| Cash paid for interest | (5,914,000) | (6,826,000) | — | — | — | — |
| Cash paid (refunded) for income taxes | 425,000 | (1,249,000) | — | — | — | — |
| Operating lease additions | 2,074,000 | 4,229,000 | — | — | — | — |
| Equipment loan additions | 23,828,000 | 25,304,000 | — | — | — | — |
| Finance lease additions | 842,000 | 1,975,000 | — | — | — | — |
| Purchases of property and equipment in ending accounts payable | 2,161,000 | 214,000 | — | — | — | — |
| Net income (loss) | — | — | (2,784,000) | 4,839,000 | (6,174,000) | (3,703,000) |
| Loss from discontinued operations | — | — | — | — | — | (869,000) |
| Depreciation and amortization | — | — | 40,163,000 | 23,040,000 | 17,786,000 | 14,538,000 |
| Stock-based compensation | — | — | 5,280,000 | 5,493,000 | 4,952,000 | 171,000 |
| Bad debt expense | — | — | — | — | 7,957,000 | 6,441,000 |
| Change in inventory reserve | — | — | — | — | (45,000) | (31,000) |
| Loss (gain) on disposal of property and equipment | — | — | (75,000) | 45,000 | (94,000) | (74,000) |
| Transaction cost related to issuance of financial liability | — | — | — | — | — | 210,000 |
| Other income from government grant | — | — | — | (4,885,000) | — | (1,166,000) |
| Loss on extinguishment of debt | — | — | 30,000 | 281,000 | — | — |
| Amortization of financing costs and accretion of purchase price payable | — | — | 591,000 | 251,000 | 140,000 | 5,000 |
| Accretion of purchase price payable | — | — | — | — | 38,000 | — |
| Interest expense, net of amortization and accretion | — | — | 6,016,000 | 1,828,000 | 932,000 | 950,000 |
| Cash paid for interest | — | — | (6,026,000) | (2,007,000) | — | — |
| Loss (gain) on foreign currency transactions | — | — | (108,000) | 144,000 | 173,000 | (454,000) |
| Loss on fair value of warrants | — | — | — | — | 2,112,000 | 198,000 |
| Share of loss in equity method investment | — | — | 89,000 | — | — | — |
| Loss (gain) loss on fair value of convertible debentures | — | — | — | (1,150,000) | 3,591,000 | 2,437,000 |
| Loss on settlement of shares to be issued | — | — | — | 442,000 | — | — |
| Provision (benefit) for income taxes | — | — | 85,000 | (1,904,000) | — | — |
| Cash paid for income taxes | — | — | (680,000) | (653,000) | — | — |
| Deferred income taxes | — | — | — | — | (3,800,000) | — |
| Adjustments to purchase price payable | — | — | (96,000) | (178,000) | — | — |
| Net increase in accounts receivable | — | — | (3,063,000) | (201,000) | (8,825,000) | (5,115,000) |
| Net increase in inventory | — | — | (60,000) | (2,419,000) | (44,000) | (1,730,000) |
| Net (increase) decrease in prepaid and other current assets | — | — | (2,239,000) | 450,000 | (858,000) | 115,000 |
| Net increase in deferred revenue | — | — | 240,000 | 31,000 | 333,000 | 366,000 |
| Net increase in accounts payables and accrued liabilities | — | — | 3,173,000 | 2,897,000 | 518,000 | 1,745,000 |
| Net cash flow provided by operating activities | — | — | 40,536,000 | 26,344,000 | 18,692,000 | 14,034,000 |
| Purchase of property and equipment | — | — | (6,852,000) | (9,161,000) | (5,046,000) | (91,000) |
| Cash proceeds from sale of property and equipment | — | — | 65,000 | 193,000 | 98,000 | 253,000 |
| Cash paid for acquisitions, net of cash acquired | — | — | (76,038,000) | (33,525,000) | (12,890,000) | (8,015,000) |
| Net cash flow used in investing activities | — | — | (82,825,000) | (42,493,000) | (17,838,000) | (7,853,000) |
| Repayments of loans | — | — | (20,447,000) | (11,900,000) | (13,893,000) | (12,970,000) |
| Repayments of leases | — | — | (4,377,000) | (3,822,000) | — | — |
| Proceeds from credit facility | — | — | — | 12,000,000 | — | — |
| Issuance of debt under senior credit facility | — | — | 64,000,000 | — | — | — |
| Repayments of senior credit facility | — | — | (2,650,000) | — | — | — |
| Net (payments) borrowings on the revolving credit facility | — | — | (7,000,000) | — | — | — |
| Issuance costs relating to credit facility | — | — | (581,000) | (1,779,000) | — | (571,000) |
| Proceeds from government grant | — | — | — | — | — | 6,008,000 |
| Proceeds from exercise of warrants | — | — | — | — | 17,474,000 | 1,641,000 |
| Issuance of shares, net of issuance costs | — | — | 27,866,000 | — | — | — |
| Settlement of restricted stock units | — | — | (1,338,000) | — | — | — |
| Proceeds from exercise of stock options | — | — | 484,000 | 567,000 | 1,603,000 | 424,000 |
| Cash in lieu of shares to be issued | — | — | — | (1,100,000) | — | — |
| Proceeds from issuance of common shares | — | — | — | — | — | 19,189,000 |
| Payments of purchase price payable | — | — | (5,083,000) | (3,817,000) | (1,274,000) | — |
| Net cash flow (used in) provided by financing activities | — | — | 50,874,000 | (9,851,000) | 3,910,000 | 13,721,000 |
| Net increase (decrease) in cash | — | — | 8,585,000 | (26,000,000) | 4,764,000 | 19,902,000 |
| Effect of exchange rate changes on cash held in foreign currencies | — | — | 108,000 | (96,000) | 621,000 | (383,000) |
| Cash, beginning of year | — | 17,209,000 | 8,516,000 | 34,612,000 | 29,227,000 | 9,708,000 |
| Cash, end of year | — | — | 17,209,000 | 8,516,000 | 34,612,000 | 29,227,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.